Skip to main content
. 2016 Jan 1;32(1):32–43. doi: 10.1089/aid.2015.0182

FIG. 4.

FIG. 4.

Receiver operating characteristic (ROC) curves for plasma tenofovir (TFV) (left) and PBMC TFV-DP (right). The legend for each figure indicates the dose frequency ranging from one to seven doses per week and the associated area under the curve (AUC) for the ROC curve.